For the 6th year, the Nordic Star Awards was presented at the end of the NLSDays conference, honoring three innovative life science companies in the Nordic region.
Nordic Stars Awards were introduced in 2013 in special recognition of life science companies in the Nordic region demonstrating outstanding innovation and entrepreneurial skills.
“At SwedenBIO we are proud to present the three winners of the Nordic Stars Award 2018. Each of them constitutes an excellent example of how companies from the Nordics succeed in developing solutions that can contribute to better healthcare globally,” said Björn Ursing, Chairman of the Nordic Stars Award.
The three winners
And the lucky winners this year were Beactica (Sweden), BlueSense Diagnostics (Denmark) and Optomed (Finland).
Beactica has through a series of EU-grants and discovery collaborations with several global pharmaceutical companies proved to be a trusted partner in fragment-based lead generation. They have also used their proprietary methodologies to pursue their own drug discovery programs in oncology, attracting widespread interest from both investors and international pharma companies.
BluSense Diagnostics has developed an innovative point-of-care platform for accurate, portable and affordable infectious disease diagnostics. With a grant from European Innovation Council pilot (EIC pilot) and CE-marking for their reader and the first diagnostic test for acute dengue fever, they are now on the verge of a market launch, less than four years after incorporation.
Optomed has made fundus screening readily available and affordable for even small practices. Their devices in combination with AI-based software have enhanced detection of diabetic retinopathy. In addition to having a medical device filling specific needs, they have been successful in commercialization, making it available to patients worldwide.
The awards were presented at the conclusion of the Nordic Life Science Days in Stockholm 2018.
Photo: From left: Filippo Bosco, CEO and founder, Blusense Diagnostics; Per Källblad, CEO, Beactica and Alpo Keinänen, Design Director, Optomed.
Photographer: Camille Sonally